Sponsor or institution
Clinical trials and research at Advenchen Laboratories, LLC
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Advenchen Laboratories, LLC that are recruiting, at sites in 5 countries (most in China (4), Spain (2), United States (2)). By phase: Phase 3 (2), Phase 2 (1), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AL8326 plus toripalimab for advanced solid tumors | Phase 1/2 | Beijing, Beijing Municipality and 14 other locations | Recruiting | Feb 6, 2026 |
| AL58805 treatment for people with advanced solid tumors. | Phase 1 | Changsha, Hunan | Recruiting | Sep 17, 2025 |
| Evaluating AL8326 for Small Cell Lung Cancer | Phase 3 | Changchun, Jilin | Recruiting | Feb 8, 2024 |
| Evaluating AL8326 for advanced small cell lung cancer treatment | Phase 2 | Birmingham, Alabama and 6 other locations | Recruiting | May 5, 2022 |
| Phase 3 test of anlotinib (AL3818) versus dacarbazine in advanced alveolar soft part sarcoma, leiomyosarcoma, and synovial sarcoma | Phase 3 | Phoenix, Arizona and 23 other locations | Recruiting | Jan 11, 2017 |
All recruiting trials (5)
-
AL8326 plus toripalimab for advanced solid tumors
This study will test whether taking AL8326 tablets together with toripalimab is safe and helps adults with advanced or metastatic solid tumors who have progressed after or have no standard treatment options.
-
AL58805 treatment for people with advanced solid tumors.
This Phase I dose-escalation trial will test different oral doses of AL58805 in people with advanced solid tumors who have exhausted standard treatment options.
-
Evaluating AL8326 for Small Cell Lung Cancer
This study is testing a new pill called AL8326 to see if it can help people with small cell lung cancer who have not responded to other treatments.
-
Evaluating AL8326 for advanced small cell lung cancer treatment
This study is testing a new drug called AL8326 to see if it can help people with advanced small cell lung cancer who need a second treatment option.
-
Phase 3 test of anlotinib (AL3818) versus dacarbazine in advanced alveolar soft part sarcoma, leiomyosarcoma, and synovial sarcoma
This trial tests whether anlotinib (AL3818) helps adults with advanced alveolar soft part sarcoma, while earlier arms compared anlotinib to dacarbazine for leiomyosarcoma and synovial sarcoma that are no longer enrolling.
Quick answers
How many clinical trials run by Advenchen Laboratories, LLC are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (4 trials), Spain (2 trials), United States (2 trials), Italy (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.